HDBuzz Prizewinner 2012: Deep brain stimulation to treat uncontrollable movements called chorea in Huntington's disea
Prana Biotech's PBT2 trial in Huntington's disease: what we know so far & what copper has to do with the mutant prote
European Medicines Agency (EMA) tells NeuroSearch a European license for Huntexil in HD requires another large trial
How can we improve recruitment into Huntington's disease clinical trials? Talking directly with families works!
Dimebon fails to improve symptoms in HD patients in the HORIZON trial
Bad news for Huntexil – the FDA requires another trial before it can be approved in the US
Success for brain ‘gene therapy’ in Parkinson’s disease – good news for similar treatments being developed in HD
Dimebon – disappointing results in an Alzheimer’s disease trial, but hope remains for HD.
Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex